BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

Iversen, Peter; Tyrrell, C.; V. Kaisary, Amir; Anderson, John; VAN POPPEL, HEIN; L.J. Tammela, Teuvo; C. Chamberlain, M.; Carroll, Kevin; Melezínek, I.

doi:10.1016/s0022-5347(05)67032-2

Public

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

Published in The Journal of Urology • Nov 1, 2000

Authors:

Peter Iversen

C. Tyrrell

Amir V. Kaisary

Abstract

PURPOSE: Nonsteroidal antiandrogen monotherapy may be a treatment option for some patients with advanced prostate cancer. We report a survival and safety update from an analysis of 2 studies in which patients with nonmetastatic (M0) locally advanced disease were treated with either 150 mg. bicalutam...

Subject

Medicine

Bicalutamide

Prostate cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!